Stocks making the biggest moves premarket: Oracle, General Motors, Coca-Cola, Spotify & more

Pre-bell trading was mixed but active across multiple earnings names: Oracle fell more than 5% on concerns about OpenAI's ability to fund AI spend, while chip stocks Nvidia and AMD also slipped. Notable gainers included General Motors, up more than 5% after raising 2026 guidance and beating Q1 EPS at $3.70 vs. $2.62 expected, Coca-Cola up 2% after beating estimates with 86 cents EPS on $12.47 billion revenue, and Bed Bath & Beyond up 25% on a narrower-than-expected loss and higher revenue. Several others moved sharply on guidance or results, including Spotify down nearly 12%, UPS down nearly 3%, Rambus down 18%, LendingClub up nearly 10%, and Sanmina up more than 6% after issuing stronger third-quarter EPS guidance and authorizing a $600 million buyback.

Analysis

The clearest second-order read is that the market is no longer rewarding any AI spend category equally; it is starting to distinguish between demand pull and capacity build. Oracle’s weakness, plus the sympathy move in Nvidia and AMD, signals that investors are questioning the durability of upstream infrastructure ordering if the application layer cannot monetize quickly enough. That is a meaningful regime shift for semis: valuation support becomes more dependent on actual utilization and not just announced capex.

In contrast, the earnings beats in GM, KO, LC, SANM, and NUE show that the market is still willing to pay for self-help, pricing discipline, and balance-sheet flexibility. The common thread is that these names are either improving margin structure or returning capital at a time when revenue growth alone is not being rewarded. Sanmina’s buyback authorization is particularly important because it converts cyclical manufacturing exposure into a capital return story, which can compress downside in a slowing macro.

The biggest overreaction may be in Spotify, where the move reflects margin disappointment rather than a demand collapse. That creates a near-term window for short-vol strategies if the stock has already de-rated to a lower expectations base, but it also reinforces that platform companies with high fixed content costs are vulnerable to even modest operating leverage misses. The weakness in UPS and JetBlue suggests transport remains a late-cycle tell: volumes are less important than pricing and cost absorption, and any slowdown in shipments tends to show up quickly in guidance cuts.

The contrarian angle is that the market may be over-penalizing the AI supply chain on a single demand-check headline while underestimating how much incremental demand can reappear if enterprise deployment accelerates in the next two quarters. But until that proof point emerges, the cleaner trade is to favor idiosyncratic execution winners over thematic beta. In other words: buy companies with visible buybacks and raised outlooks, and fade names whose earnings quality depends on a still-unproven demand cycle.

Key Decisions for Investors

• Short ORCL / long SANM as a 1-3 month pair: expresses weaker AI spend durability versus a manufacturer with improving outlook and buyback support; target 8-12% relative performance if semiconductor ordering normalizes lower.
• Buy GM on strength for a 3-6 month trade, but hedge with puts into the next macro data release: the raised outlook gives near-term upside, yet auto multiples remain highly sensitive to credit and consumer-demand deterioration.
• Initiate a tactical long LC for 4-8 weeks: the name has positive operating momentum and should keep working if credit performance holds; use a tight stop if net interest margin compresses again.
• Fade SPOT into rallies via call spreads or a short against a basket of profitable software names: the market is punishing margin misses more than revenue misses, so upside likely caps until the next guidance reset.
• Avoid adding to NVDA/AMD on this tape; if you want AI exposure, rotate toward names with direct monetization or capital return. Use any further weakness to build only if Oracle stabilizes over the next 2-4 weeks.